IRISH JONES: Open Payments
NPI 1366909442 · OCEAN CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 26 payments from 9 companies in 2025. Trend: 2023 $131 · 2024 $354 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $189 |
| Axsome Therapeutics, Inc. | 3 | $172 |
| Otsuka America Pharmaceutical, Inc. | 6 | $135 |
| Janssen Pharmaceuticals, Inc | 3 | $72 |
| Neurocrine BioSciences, Inc. | 3 | $58 |
| Indivior Inc. | 2 | $37 |
| Alkermes, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: COBENFY, Auvelity, INVEGA SUSTENNA, ABILIFY ASIMTUFII, INGREZZA, REXULTI, SUBLOCADE, ARISTADA.
Industry payments across MD — which companies pay providers there.
